Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
About this item
Full title
Author / Creator
Masuda, Norikazu , Lee, Soo-Jung , Ohtani, Shoichiro , Im, Young-Hyuck , Lee, Eun-Sook , Yokota, Isao , Kuroi, Katsumasa , Im, Seock-Ah , Park, Byeong-Woo , Kim, Sung-Bae , Yanagita, Yasuhiro , Ohno, Shinji , Takao, Shintaro , Aogi, Kenjiro , Iwata, Hiroji , Jeong, Joon , Kim, Aeree , Park, Kyong-Hwa , Sasano, Hironobu , Ohashi, Yasuo and Toi, Masakazu
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
Patients who complete neoadjuvant chemotherapy for breast cancer without a pathological complete response have a high risk of relapse. A randomized trial comparing capecitabine with no additional adjuvant therapy showed that capecitabine prolonged disease-free and overall survival.
Patients who have residual invasive breast cancer after the rece...
Alternative Titles
Full title
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
Authors, Artists and Contributors
Author / Creator
Lee, Soo-Jung
Ohtani, Shoichiro
Im, Young-Hyuck
Lee, Eun-Sook
Yokota, Isao
Kuroi, Katsumasa
Im, Seock-Ah
Park, Byeong-Woo
Kim, Sung-Bae
Yanagita, Yasuhiro
Ohno, Shinji
Takao, Shintaro
Aogi, Kenjiro
Iwata, Hiroji
Jeong, Joon
Kim, Aeree
Park, Kyong-Hwa
Sasano, Hironobu
Ohashi, Yasuo
Toi, Masakazu
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1904903149
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1904903149
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1612645
